Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-08 to 2024-02-09
Current total value of award: $2555.18
Description: 4563601531!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML